An artificial hair follicle and its in vitro construction method and application
By mixing dermal papillary cells and hair follicle stem cells in vitro, and using specific induction medium to form artificial hair follicles, the problem of inefficient and inflammatory responses in the existing technology is solved, and efficient and non-inflammatory responses are achieved. hair follicle amplification and hair regeneration in the body.
Patent Information
- Application Number
- CN202311615842.3
- Authority / Receiving Office
- CN · China
- Patent Type
- Patents(China)
- Current Assignee / Owner
- Filing Date
- 2023-11-30
- Publication Date
- 2024-11-15
- Estimated Expiration
- 2043-11-30
AI Technical Summary
The prior art is inefficient when constructing human hair follicle organoids in vitro, uncontrollable direction of new hair, accompanied by inflammatory reactions, and cannot meet the needs of patients with severe hair loss.
By mixing dermal papillary cells and hair follicle stem cells in vitro and culture them in a specific proportion, the formation of artificial hair follicles is induced using a specific induction medium to form artificial hair follicles with controllable size and complete functions.
The artificial hair follicle amplification was achieved 20-30 times, and its morphology was highly similar to that of native hair follicles. It has no inflammatory response after transplantation, and can form a complete new hair follicle structure in the body.
Smart Images

Figure BDA0004578032990000061 
Figure BDA0004578032990000072 
Figure BDA0004578032990000073
Abstract
Description
Technical Field
[0001] The present invention belongs to the field of stem cells and regenerative medicine, and mainly involves the acquisition of stem cells and the in vitro induction technology of hair follicle organoids. The sub-fields belong to cell biology and developmental biology. Background Art
[0002] Hair loss is a common skin disease and a global problem. There are many causes of hair loss, but the biological essence is that the cyclical growth of the patient's hair follicles is blocked, and the patient cannot smoothly enter the next growth phase from the resting phase, which eventually leads to hair follicle necrosis and hair loss. At present, the treatment of hair loss mainly uses two methods: drug therapy and autologous hair follicle transplantation.
[0003] The current hair loss treatment drugs represented by finasteride and minoxidil are not specific drugs for hair loss, and have obvious side effects. The animal model for the development of hair follicle drugs is generally based on the mouse model. The differences between mice and humans lead to a high failure rate in the current hair follicle drug development. If a substitute for human hair follicles can be constructed in vitro, it will provide a better drug development model for in vitro hair follicle drug development, which will help develop truly effective and safe drugs for early hair loss and gray hair in humans.
[0004] Autologous hair follicle transplantation only changes the location of hair follicles, migrating them from one area of the scalp (such as the occipital region) to the area of hair loss, but does not change the number of hair follicles, which is far from meeting the needs of patients with severe hair loss. With the development of stem cells and regenerative medicine, cell therapy aimed at regenerating hair follicles has become a possible alternative to traditional autologous hair follicle transplantation.
[0005] Dermal papilla cells (DPCs) are active specialized fibroblast-like cell clusters derived from the skin stroma, and hair follicle stem cells (HFSCs) are a group of resident epithelial-like stem cells located at the enlarged end of the hair follicle neck. Both play a key role in the occurrence, development and cyclical growth of hair follicles.
[0006] After searching, Chinese invention patent CN201580034253.3 discloses a composition for preventing hair loss and promoting hair growth, a method for manufacturing the composition and its use, wherein the composition contains small-sized stem cells (especially small stem cells with a diameter of less than 8 μm) or a culture medium thereof as an active ingredient; and the use of the composition is to maintain the hair growth promoting function through small-sized stem cells with a diameter of less than 8 μm, and the hair growth promoting function significantly increases the activation of hair follicle stem cells in the resting phase. In the prior art, there is generally a strategy of mixing two groups of stem cells and then directly transplanting them into the body to induce hair regeneration, and hair regeneration can be observed, but the disadvantage is that the efficiency of new hair is very low, the size of new hair follicles is different, the direction of hair is uncontrollable, and it is accompanied by obvious inflammatory reactions. <Master>·Medical and Health Technology·Basic Medicine; 2020.01 Li Zhehao from Southern Medical University disclosed the basic method of reconstructing mouse hair follicle organoids by culturing mouse hair follicle stem cells and hair papilla cells in vitro, and explored the effects of epidermal cells in the embryonic period (E14.5) and epidermal cells at 6 days after birth (P6) on the construction of hair follicle organoids, but this study did not explore whether this technology is also applicable to the construction of hair follicle organoids based on adult mice or adults. Therefore, it is urgent to develop a more universal new strategy for constructing hair follicle organoids or artificial hair follicles in vitro. Summary of the invention
[0007] The present invention aims to overcome the deficiencies of the prior art and invents an organoid technology that induces the self-assembly of a mixture of dermal papilla cells DPCs and hair follicle stem cells HFSCs into artificial hair follicles in vitro, which have the ability to induce hair regeneration. The present invention can construct artificial hair follicle organs with controllable size, complete structure and function in vitro, which are mainly used in the development of in vitro hair follicle-related drugs or in vivo hair follicle transplantation, the latter of which can regenerate hair in vivo.
[0008] The technical solution of the present invention is:
[0009] One of the technical solutions of the present invention:
[0010] An artificial hair follicle, comprising dermal papilla cells and hair follicle stem cells according to the dermal papilla cells: hair follicle stem cells
[0011] =0.1:1-10:1 ratio, and then cultured in vitro to obtain the dermal papilla cells and hair follicle stem cells. The dermal papilla cells and hair follicle stem cells are both selected from cells within the P10 generation, and the dermal papilla cells and hair follicle stem cells are derived from animal dermal cells or epidermal cells.
[0012] Preferably, the dermal papilla cells and the hair follicle stem cells are mixed in a ratio of dermal papilla cells:hair follicle stem cells=0.1:1-5:1.
[0013] The second technical solution of the present invention:
[0014] An in vitro method for constructing artificial hair follicles comprises the following steps:
[0015] The artificial hair follicles are obtained by mixing dermal papilla cells and hair follicle stem cells in a certain ratio and culturing them in vitro. The specific in vitro construction method of artificial hair follicles includes the following steps:
[0016] (1) obtaining dermal papilla cells and hair follicle stem cells respectively, and selecting cells within the P10 generation;
[0017] (2) The separated single cell suspension is labeled with a flow cytometry antibody labeled with a fluorescent dye, and DPCs and HFSCs are flow-sorted;
[0018] (3) mixing DPCs and HFSCs in proportion, resuspending in Matrigel, adding organoid induction medium and culturing for 7-9 days; the mixture is a mixture of dermal papilla cells and hair follicle stem cells in a quantitative ratio of 0.1:1 to 10:1;
[0019] The components and final concentrations of the organoid induction medium are: R-Spondin 1 100-200 ng / mL; Wnt-3a 10-100 ng / mL; Noggin 5-50 ng / mL; A83-015-100 nM; SB202190 1-5 μM; Y-27632 1-50 μM; EGF 1-500 ng / mL; bFGF 0.1-100 ng / mL; Hydrocortisone 0.5-1 μg / mL; Nicotinamide 2-10 mM; B27 supplement 0.5%-5%; N2 0.5%-5%; GlutaMax 100x 0.5%-5%; Hepes 1-10 mM; Penicillin / Streptomycin 0.8%-1.2%; Primocin 10-100 μg / mL;
[0020] Alternatively, the composition and final concentration of the culture medium are: R-Spondin 1 0.1-1 μg / mL; Wnt-3a 10-100 ng / mL; BMP4 1-25 ng / mL; Y-27632 1-50 μM; EGF 1-500 ng / mL; bFGF 0.1-100 ng / mL; Hydrocortisone 0.3-0.5 μg / mL; Nicotinamide 8-12 mM; B27 supplement 0.5%-5%; N2 0.5%-5%; GlutaMax 0.5%-5%; Hepes 1-10 mM;
[0021] Penicillin / Streptomycin 0.8%-1.2%; Primocin 10-100μg / mL;
[0022] The solvent is Advanced DMEM / F12; percentage content: 1% indicates the volume percentage.
[0023] Preferably, the mixing is mixing the dermal papilla cells and the hair follicle stem cells in a quantitative ratio of 0.1:1 to 5:1.
[0024] Preferably, the composition and final concentration of the organoid induction medium are:
[0025] R-Spondin 1200ng / mL; Wnt-3a 100ng / mL; Noggin 25ng / mL; A83-0150 nM; SB2021902μM; Y-27632 10μM; EGF 200ng / mL; bFGF 10ng / mL; Hydrocortisone 0.5μg / mL; Nicotinamide 10mM; B27 supplement 2%; N21%; GlutaMax 100x 1%;
[0026] Hepes 5mM; Penicillin / Streptomycin 1%; Primocin 50μg / mL;
[0027] Alternatively, the composition and final concentration of the organoid induction medium are:
[0028] R-Spondin 1 1μg / mL; Wnt-3a 100ng / mL; BMP4 25ng / mL; Y-27632 10μM; EGF50ng / mL; bFGF 5ng / mL; Hydrocortisone 0.5μg / mL; Nicotinamide 10mM; B27 supplement 0.5%-5%; N2 1%; GlutaMax 1%;Hepes 10mM;
[0029] Penicillin / Streptomycin 1%; Primocin 100μg / mL.
[0030] The third technical solution of the present invention: The present invention provides the use of the artificial hair follicles or the artificial hair follicles constructed by the above method in the preparation of in vitro hair follicle-related drugs.
[0031] Technical solution 4 of the present invention: The present invention provides the use of the artificial hair follicles or the artificial hair follicles constructed by the above method in the preparation of a preparation for promoting in vivo hair regeneration.
[0032] The fifth technical solution of the present invention:
[0033] The invention provides a culture medium, the components and final concentrations of which are: R-Spondin 1 100-200 ng / mL; Wnt-3a 10-100 ng / mL; Noggin 5-50 ng / mL; A83-015-100 nM; SB202190 1-5 μM; Y-27632 1-50 μM; EGF 1-500 ng / mL; bFGF 0.1-100 ng / mL; Hydrocortisone 0.5-1 μg / mL; Nicotinamide 2-10 mM; B27 supplement 0.5%-5%; N2 0.5%-5%; GlutaMax 100x 0.5%-5%; Hepes 1-10 mM; Penicillin / Streptomycin 0.8%-1.2%; Primocin 10-100 μg / mL;
[0034] Alternatively, the composition and final concentration of the culture medium are: R-Spondin 1 0.1-1 μg / mL; Wnt-3a 10-100 ng / mL; BMP4 1-25 ng / mL; Y-27632 1-50 μM; EGF 1-500 ng / mL; bFGF 0.1-100 ng / mL; Hydrocortisone 0.3-0.5 μg / mL; Nicotinamide 8-12 mM; B27 supplement 0.5%-5%; N2 0.5%-5%; GlutaMax 0.5%-5%; Hepes 1-10 mM;
[0035] Penicillin / Streptomycin 0.8%-1.2%; Primocin 10-100μg / mL;
[0036] The solvent is Advanced DMEM / F12; percentage content: 1% indicates the volume percentage.
[0037] The present invention also provides application of the culture medium in in vitro construction of artificial hair follicles.
[0038] Compared with the prior art, the advantages of the present invention are:
[0039] 1. Through the hair follicle organoid technology of the present invention, one hair follicle can be transformed into 20-30 artificial hair follicles, which is 20-30 times the original. Figure 4 A and Figure 4 As shown in B, after the cells from one initial hair follicle are processed by the steps of the present invention, 20-30 artificial hair follicle spheres can be formed under optimized conditions. This technology can solve the technical and medical bottleneck that the current traditional hair follicle transplantation technology cannot expand hair follicles.
[0040] 2. The artificial hair follicles constructed in vitro by the method of the present invention have a very high morphological similarity with the original native hair follicles, and after digestion with digestive fluid, the keratinized hair / hair shaft tissue that is not digested by trypsin and collagenase is retained ( Figure 5 ).
[0041] 3. The artificial hair follicles (HF001) constructed in vitro and the original hair follicles (HF002) of the present invention have a high degree of similarity ( Figure 6 ).
[0042] 4. The artificial hair follicles constructed in vitro by the present invention showed complete new hair follicle structure in the mouse skin of the artificial hair follicle transplantation group, and there was no obvious inflammatory reaction ( Figure 7 ).
[0043] In summary, the present invention discloses a new method for constructing artificial hair follicles in vitro. The artificial hair follicles constructed based on this method can be used for in vitro drug development to screen out highly effective drugs for human gray hair or hair loss; on the other hand, they can be used for in vivo transplantation to achieve hair regeneration.
[0044] The detailed structure of the present invention is further described below in conjunction with the accompanying drawings and specific implementation methods. BRIEF DESCRIPTION OF THE DRAWINGS
[0045] Figure 1 This is a diagram of the process of obtaining native hair follicles from mouse vibrissae, where (A) the native hair follicles come from newborn mice aged 7-9 days; (B) the overall structure of mouse vibrissa tissue under a stereomicroscope (4x); (C) a single hair follicle surgically extracted is observed under a stereomicroscope.
[0046] Figure 2 Figure 2 is a diagram of the sorting and labeling process of hair follicle DPCs and HFSCs, including (A) the anatomical location of hair follicle DPCs and HFSCs, and a flow chart of flow and fluorescent labeling; (B) flow cytometry is used to first obtain a cell population that is double-positive for intergrinα6 and intergrinβ1, and then CD34 and Sca-1 double-positive cells are sorted out from them to obtain HFSCs; (C) The left picture is a blank control, and the right picture is stained with CD133 and SOX-2, and double-positive cells are sorted to obtain DPCs.
[0047] Figure 3 These are bright field (A) and fluorescence (B) images of DPCs and HFSCs infected with lentivirus labeled with green fluorescent protein and red fluorescent protein, respectively, and then the two groups of cells labeled with different fluorescent markers were mixed in Matrigel.
[0048] Figure 4 The following is a comparison of the formation status of in vitro hair follicle organoids under different induction systems, including (A) Matrigel / OIM1 culture system; (B) Matrigel / OIM2 culture system; (C) Matrigel / OIM3+OMM system; (D) Matrigel / OIM4+OMM system. Figure 4 A and Figure 4 The number of hair follicle organoids formed by the B system was higher than that of Figure 4 C and Figure 4 The D system has obvious advantages, but Figure 4 There are too many mesenchymal cells attached to the wall in A, which is not conducive to the expansion and maturation of hair follicle organoids in the later stage. Statistics show that there are large differences in the efficiency, size, consistency and ability to induce hair regeneration of artificial hair follicle micro-organs produced under different organoid induction culture medium systems. In particular, OIM3 and OIM4 have almost no ability to induce hair regeneration, while OIM1 has the highest in vitro induction efficiency, but its consistency and ability to induce hair regeneration are not as good as OIM2 (Table 7). Therefore, in the subsequent examples, Matrigel / OIM2 was selected as the culture system for in vitro organoid construction.
[0049] Figure 5 The artificial hair follicles constructed in vitro have extremely high morphological similarity with the original native hair follicles, and after digestion with digestive fluid, they retain pictures of keratinized hair / hair shaft tissue that is not digested by trypsin and collagenase.
[0050] Figure 6 The single-cell sequencing and analysis results of the artificial hair follicles (HF001) constructed in vitro and the initial native hair follicles (HF002) showed that the two were highly similar. Figure 6 A shows the cell clustering analyzed by single-cell sequencing of hair follicle tissue, which mainly includes hair follicle cells, vascular cells, fibroblast-like cells, immune cells, melanocytes, muscle cells and other cells; Figure 6 B shows a comparison of single-cell sequencing of hair follicle organoids (HF001-2) and original hair follicle tissue (HF002). It was found that hair follicle organoids contain core cell groups such as hair follicle cells and fibroblast-like cells that constitute the hair follicle structure, indicating that hair follicle organoids have tissue consistency with original hair follicle tissue.
[0051] Figure 7 This is the experimental result of implanting artificial hair follicles into mice, in which the single cell suspension of native hair follicles of newborn mice was injected ( Figure 7 A) or implanted into artificial hair follicles constructed in vitro ( Figure 7 B) was inserted into the subcutaneous tissue of nude mice. After 29 days, it was found that the nude mice in the artificial hair follicle transplantation group had grown hair ( Figure 7 C); Light microscopic comparison of subcutaneous tissues of two groups of nude mice ( Figure 7 D) and tissue H&E staining comparison ( Figure 7 E) Demonstrates that the mice in the artificial hair follicle transplantation group had complete new hair follicle structures and no obvious inflammatory response.
[0052] Figure 8 The unsorted dermal and epidermal cells were mixed and then induced to form hair follicle organoids using the Matrigel / OIM2 culture system. The light microscope showed that a structure similar to hair was formed. Figure 8 A is a structural photo taken under a 40x microscope; Figure 8 B is a structural photograph taken under a 100x microscope.
[0053] Fig. 9 The single cell suspension of primary hair follicles of newborn mice was injected Fig. 9 A) or implanted into artificial hair follicles constructed in vitro ( Fig. 9 B) The artificial hair follicles were transplanted into the subcutaneous tissue of nude mice. Comparison of H&E staining images showed that complete new hair follicle structures appeared in the skin of mice in the artificial hair follicle transplantation group.
[0054] Fig.10 ESCs and DCs isolated from the dorsal tissue of newborn 24-hour-old mice were mixed in a 1:1 ratio and induced to form hair follicle organoids using the Matrigel / OIM2 culture system. The structure similar to hair was formed under a light microscope. Fig.10 A is a structural photo taken under a 40x microscope; Fig.10 B is a structural photograph taken under a 100x microscope. DETAILED DESCRIPTION
[0055] Embodiment 1:
[0056] An in vitro method for constructing artificial hair follicles comprises the following steps:
[0057] (1) 7-9 day old newborn mice were killed by cervical dislocation, and the whisker tissue at both ends of the mouse's mouth was surgically removed;
[0058] (2) Under a stereomicroscope, carefully remove the complete hair follicle structure using sterile forceps;
[0059] (3) Centrifuge at 1100 rpm for 5 min; discard the supernatant, add 2 mL of preheated digestion solution, mix thoroughly, and place in a 37°C water bath for 45 min, shaking vigorously every 15 min;
[0060] (4) After the cells are digested (without DNase I treatment), add an appropriate amount of stop solution to terminate the digestion;
[0061] (7) Pass the suspension through a 70 μm filter membrane and collect the filtered cell suspension;
[0062] (8) Centrifuge at 1000 rpm for 5 min; discard the supernatant, add 2 mL of cleaning solution to resuspend, mix thoroughly and count;
[0063] The separated single cell suspension was labeled with a flow cytometry antibody labeled with a fluorescent dye, and DPCs and HFSCs were flow-sorted; DPCs and HFSCs were mixed in a ratio of 1:1 (quantity ratio), resuspended in Matrigel (Table 1), and different organoid induction solutions or time-sequential combinations (see Tables 2-6) were added and cultured for 7-9 days. The Matrigel is a prior art product.
[0064] The culture matrix Matrigel hydrogel was digested to obtain artificial hair follicles and transplanted into the subcutaneous tissue of mice.
[0065] The experimental process and results can be found in Figure 1-7 The results of Example 1 and the accompanying drawings and Table 7 show that the artificial hair follicles constructed in vitro by the present invention have a very high morphological similarity to the original native hair follicles, and that after digestion with digestive fluid, keratinized hair / hair shaft tissue that is not digested by trypsin and collagenase is retained ( Figure 5 ). Single-cell sequencing analysis of artificial hair follicles (HF001) and original native hair follicles (HF002) constructed in vitro ( Figure 6 ), the results showed that the two were highly similar. Injection of single cell suspension of primary hair follicles of newborn mice Figure 7 A or implanting artificial hair follicles constructed in vitro Figure 7 B was inserted into the nude mice's skin, and 29 days later, it was found that the nude mice in the artificial hair follicle transplantation group had grown hair. Figure 7 C; Light microscopic comparison of subcutaneous tissues of two groups of nude mice Figure 7 D and tissue H&E staining comparison Figure 7 E proves that the mouse skin in the artificial hair follicle transplantation group has complete new hair follicle structure and no obvious inflammatory response.
[0066] Table 1: Construction of different induction systems for artificial hair follicles
[0067]
[0068]
[0069] Table 2: Organoid induction medium 1 (OIM1)
[0070]
[0071] Table 3: Organoid induction medium 2 (OIM2)
[0072]
[0073] Table 4: Organoid induction medium 3 (OIM3)
[0074] Component name Final concentration Component name Final concentration FGF 4ng / mL Primocin 1‰ BMP4 2.5 ng / mL Y-27632 10μM SB431542 10μM
[0075] Table 5: Organoid induction medium 4 (OIM4)
[0076] Component name Final concentration FGF 50ng / mL LDN 200ng / mL Y-27632 10μM
[0077] Table 6: Organoid maturation medium (OMM)
[0078]
[0079] Table 7: Comparison of the efficiency, size, consistency and ability to induce hair regeneration of artificial hair follicle micro-organs produced under different organoid induction culture medium systems
[0080] Culture medium system Efficiency (output ratio) Size (diameter) consistency Induces hair regrowth OIM1 30 times 250 microns 80% 65% OIM2 27 times 200 micron diameter 87% 80% OIM3 5 times 55 micron diameter 50% none OIM4 3 times 20 micron diameter 30% none
[0081] Note: Efficiency refers to the average number of artificial hair follicle micro-organs induced to form from one initial hair follicle.
[0082] Table 8: The raw materials used in the embodiments of the present invention are all existing products; the attached table notes their functions and production companies
[0083]
[0084]
[0085] Embodiment 2:
[0086] An in vitro method for constructing artificial hair follicles comprises the following steps:
[0087] Newborn mice aged 7-9 days were killed by cervical dislocation, and the vibrissa tissues at both ends of the mouse's mouth were surgically removed;
[0088] Under a stereo microscope, use sterile forceps to carefully pick up the complete hair follicle structure;
[0089] Horizontal centrifugation at 1100 rpm for 5 min;
[0090] Discard the supernatant, add 2 mL of preheated digestion solution, mix thoroughly, and place in a 37°C water bath for 45 mins, shaking vigorously every 15 mins;
[0091] After the cells are digested (without DNase I treatment), add an appropriate amount of stop solution to terminate the digestion;
[0092] The suspension was filtered through a 70 μm filter membrane, and the filtered cell suspension was collected;
[0093] Centrifuge at 1000 rpm for 5 min;
[0094] Discard the supernatant, add 2 mL of cleaning solution to resuspend, mix thoroughly and count;
[0095] Take 5*10 4 The cells (mixed dermal and epidermal cells without sorting) were resuspended in Matrigel and cultured in the Matrigel / OIM2 culture system (Table 3) for 7-9 days.
[0096] The culture matrix Matrigel hydrogel was digested to obtain artificial hair follicles and transplanted into the subcutaneous tissue of mice; the results are shown in Figure 8 and Fig. 9 , Figure 8 The results showed that after mixing unsorted dermal and epidermal cells, the Matrigel / OIM2 culture system was used to induce the formation of hair follicle organoids, and light microscopy showed that a hair-like structure was formed. Fig. 9 The single cell suspension of primary hair follicles of newborn mice was injected Fig. 9 A) or implanted into artificial hair follicles constructed in vitro ( Fig. 9 B) The artificial hair follicles were transplanted into the subcutaneous tissue of nude mice. Comparison of H&E staining images showed that complete new hair follicle structures appeared in the skin of mice in the artificial hair follicle transplantation group.
[0097] Embodiment 3:
[0098] An in vitro method for constructing artificial hair follicles comprises the following steps:
[0099] Newborn mice within 24 hours were killed by alcohol immersion, and the specimens were washed three times with sterile saline;
[0100] In a biosafety cabinet, use sterile forceps and sterile surgical scissors to carefully take the entire back skin tissue of the mouse;
[0101] The back skin was spread in a 6-cm culture dish, 10% neutral protease was added to immerse the tissue, and it was placed at 4°C overnight;
[0102] Use forceps to carefully separate the epidermis and dermis, and cut them into pieces with surgical scissors. Add 3 mL of preheated digestion solution to each and mix thoroughly. Then place them in a 37°C water bath for digestion for 45 minutes, shaking vigorously every 15 minutes.
[0103] After observing that the cells are digested, add an appropriate amount of stop solution to terminate the digestion;
[0104] The suspensions were filtered through 70 μm filters, and the filtered cell suspensions were collected;
[0105] Centrifuge at 1000 rpm for 5 min;
[0106] Discard the supernatant, add 2 mL of cleaning solution to resuspend, mix thoroughly and count;
[0107] The single cell suspension after separation of epidermal tissue contains a large number of ESCs (Epithelial Stem Cells, epidermal stem cells; HFSCs are a type of ESCs); the single cell suspension after separation of dermal tissue contains a large number of DCs (Dermal Cells, dermal cells; DPCs are a type of DCs);
[0108] ESCs:DCs were mixed at a ratio of 1 to 1 (cell number ratio), resuspended in Matrigel, and cultured for 7-9 days in the Matrigel / OIM2 culture system (Table 3). The results are detailed in Fig.10 , Fig.10 ESCs isolated from the back tissue of 24-hour-old newborn mice were mixed with DCs in a 1:1 ratio, and the mixture was then induced to form hair follicle organoids using the Matrigel / OIM2 culture system. Light microscopy revealed the formation of hair-like structures.
[0109] The above is a specific implementation mode of the present invention, but the protection scope of the present invention is not limited thereto. Any technician familiar with the technical field, within the technical scope disclosed by the present invention, can make equivalent replacements or changes according to the technical solutions and concepts of the present invention, which should be covered by the protection scope of the claims of the present invention.
Claims
1. A method for constructing artificial hair follicles in vitro, comprising the following steps: 1) obtaining dermal papilla cells and hair follicle stem cells respectively, selecting cells within the P10 generation, wherein the dermal papilla cells and hair follicle stem cells are derived from dermal cells or epidermal cells of an animal; the animal is a mouse; 2) The separated single cell suspension is labeled with flow cytometry antibodies and DPCs and HFSCs are separated by flow cytometry; 3) DPCs and HFSCs are mixed in proportion, resuspended in Matrigel, and cultured in organoid induction medium for 7-9 days; the mixture is a mixture of dermal papilla cells and hair follicle stem cells in a ratio of 0.1:1 to 10:1; the culture environment is a common 48-well plate; The composition and final concentration of the organoid induction medium are as follows: R-Spondin 1 100-200 ng / mL; Wnt-3a 10-100 ng / mL; Noggin 5-50 ng / mL; A83-01 5-100nM; SB202190 1-5 µM; Y-27632 1-50 µM; EGF 1-500 ng / mL; bFGF 0.1-100 ng / mL; Hydrocortisone 0.5 -1µg / mL; Nicotinamide 2-10 mM; B27 supplement 0.5%-5%; N2 0.5%-5%; GlutaMax 100x 0.5%-5%; Hepes 1-10 mM; Penicillin / Streptomycin 0.8%-1.2%; Primocin 10-100 µg / mL; Alternatively, the composition and final concentration of the culture medium are: R-Spondin 1 0.1-1 µg / mL; Wnt-3a 10-100 ng / mL; BMP4 1-25 ng / mL; Y-27632 1-50 µM; EGF 1-500 ng / mL; bFGF 0.1-100 ng / mL; Hydrocortisone 0.3-0.5 µg / mL; Nicotinamide 8-12 mM; B27 supplement 0.5%-5%; N20.5%-5%; GlutaMax 0.5%-5%; Hepes 1-10 mM; Penicillin / Streptomycin 0.8%-1.2%; Primocin 10-100 µg / mL; The solvent is Advanced DMEM / F12; the percentage content indicates volume percentage.
2. The in vitro construction method of artificial hair follicles according to claim 1, characterized in that: The mixture is made by mixing the dermal papilla cells and the hair follicle stem cells in a ratio of dermal papilla cells:hair follicle stem cells=0.1:1-5:
1.
3. The in vitro construction method of artificial hair follicles according to claim 2, characterized in that: The components and final concentrations of the organoid induction medium are: R-Spondin 1 200 ng / mL; Wnt-3a 100 ng / mL; Noggin 25 ng / mL; A83-01 50 nM; SB202190 2 µM; Y-27632 10 µM; EGF 200 ng / mL; bFGF 10 ng / mL; Hydrocortisone 0.5µg / mL; Nicotinamide 10 mM; B27 supplement 2%; N2 1%; GlutaMax 100x 1%; Hepes 5mM; Penicillin / Streptomycin 1%; Primocin 50 µg / mL; Alternatively, the composition and final concentration of the organoid induction medium are: R-Spondin 1 1 µg / mL; Wnt-3a 100 ng / mL; BMP4 25 ng / mL; Y-27632 10 µM; EGF50ng / mL; bFGF 5 ng / mL; Hydrocortisone 0.5 µg / mL; Nicotinamide 10 mM; 1%; GlutaMax 1%; Hepes 10 mM; Penicillin / Streptomycin 1%; Primocin 100 µg / mL.
Citation Information
Cited By
Preparation method of mouse skin organoid
CN120758442A
